Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Vaxcyte, Inc.

NASDAQ: PCVX · Life Sciences · 10 alerts · CIK 1649094

Share price
$61.61Close, Nov 16
Market cap
$9.75B
Shares outstanding
158.3MLatest SEC cover page
Sector
Life Sciences
Industry
Biological Products, (No Diagnostic Substances)SIC 2836

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Vaxcyte, Inc. filings on SEC EDGAR ↗

4:10 PM ET Form 4
Insider Selling

Vaxcyte Chief Technical Ops Officer Harpreet S. Dhaliwal Sells $1.15M of Stock

Harpreet S. Dhaliwal, Chief Technical Ops Officer, sold 17,000 shares of Vaxcyte, Inc. at $67.33 to $68.82 a share (average $67.83) in 3 transactions, worth $1.15M in total on Nov 11, 2026. Shares held after the trade: 68,085 (-0.8%).

Value
$1.15M
Shares
17,000
Average price
$67.83
Role
Chief Technical Ops Officer
Holding change
-0.8%
Trade date
Nov 11, 2026
4:52 PM ET Form 4
Insider Selling

Vaxcyte SVP, Finance & CAO Elvia Cowan Sells $183K of Stock

Elvia Cowan, SVP, Finance & CAO, sold 3,000 shares of Vaxcyte, Inc. at $60.77 to $61.55 a share (average $60.92) in 2 transactions, worth $183K in total on Nov 2, 2026. Shares held after the trade: 27,860 (-2.1%).

Value
$183K
Shares
3,000
Average price
$60.92
Role
SVP, Finance & CAO
Holding change
-2.1%
Trade date
Nov 2, 2026
4:52 PM ET Form 4
Insider Selling

Vaxcyte EVP, Chief Scientific Ofc, COO Jim Wassil Sells $137K of Stock

Jim Wassil, EVP, Chief Scientific Ofc, COO, sold 2,250 shares of Vaxcyte, Inc. at $60.78 to $61.57 a share (average $60.90) in 2 transactions, worth $137K in total on Nov 2, 2026. Shares held after the trade: 145,435 (-0.2%).

Value
$137K
Shares
2,250
Average price
$60.90
Role
EVP, Chief Scientific Ofc, COO
Holding change
-0.2%
Trade date
Nov 2, 2026

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.